Gadolinium Buildup a Risk to Healthy Brains

Magnetic Resonance Imaging (MRI) is a commonly used diagnostic tool for a variety of suspected diseases. Whether attempting to determine the extent of a concussion or searching for cancer, MRIs have become ubiquitous in many fields, with hundreds of thousands of these procedures being performed every year. Often, GBCAs (Gadolinium Based Contrasting Agents) are used to facilitate the process.

GBCAs were used for years before people acknowledged the danger presented by Gadolinium. Doctors and radiologists explained away patient symptoms, either claiming the disease being initially diagnosed was the culprit, or that the patient was only imagining debilitating after-effects. Finally, doctors have begun to accept the existence of Gadolinium Deposition Disease (GDD).

The symptoms of GDD are varied, including headaches, ringing in the ears, sensitivity to light, and many others that make life difficult for sufferers. Though the exact reason for these symptoms is not clear, it is known that Gadolinium build-up in three parts of the body is associated with GDD. These three parts of the body are the brain, bones, and skin.

The effects of damage to the brain are well-established due to hundreds of years of observing other diseases that attack the central nervous system. Understanding why brain fog, headaches, and other symptoms occur is simple when the organ under attack is the brain. Scientists are still attempting to discern the effects of Gadolinium build-up in the skin and bones, and it could be years or even decades before the disease is fully understood.

If you have suffered GDD and are struggling with daily living skills or the ability to hold a job, or if you are suffering pain or other side effects, it is important to hold the medical establishment accountable for the use of dangerous substances. Please consult with an experienced attorney regarding your case.